Diabetics Starting With Sulfonylureas Had More
Cardiac Events
While metformin generally is considered first-line treatment for diabetes, many patients are started on sulfonylureas, often because of side-effect issues.
A new study of more than a quarter million veterans recommends against that practice, citing a surprising increase in risk of acute myocardial infarction, stroke, or death.